Overview
Creatine deficiency syndrome (also called cerebral creatine deficiency syndrome) is a group of inherited metabolic disorders where the body cannot make or transport creatine properly. Creatine is a natural substance that helps supply energy to the brain and muscles. Without enough creatine reaching the brain, the nervous system cannot work as it should. There are three main types: guanidinoacetate methyltransferase (GAMT) deficiency, arginine:glycine amidinotransferase (AGAT) deficiency, and creatine transporter deficiency (CTD, also called SLC6A8 deficiency). All three types share many of the same symptoms but are caused by problems in different genes. The most common features include intellectual disability, delayed speech and language development, behavioral problems, seizures, and low muscle tone. The good news is that two of the three types — GAMT deficiency and AGAT deficiency — can be treated with creatine supplements, and early treatment can prevent or reduce brain damage. Creatine transporter deficiency is harder to treat, and researchers are actively working on new therapies. Early diagnosis through newborn screening or genetic testing is very important for the best outcomes.
Also known as:
Key symptoms:
Intellectual disability or learning difficultiesDelayed speech and language developmentBehavioral problems such as hyperactivity, aggression, or autism-like behaviorsSeizures or epilepsyLow muscle tone (floppy muscles)Delayed motor milestones such as sitting or walking latePoor attention and concentrationSelf-injurious behaviorAbsent or very limited speechMild to moderate developmental delay
Variable
Can be inherited in different ways depending on the underlying gene
Infantile
Begins in infancy, roughly 1 month to 2 years old
FDA & Trial Timeline
7 eventsHospices Civils de Lyon — NA
Assiut University
Hospital Universitari de Bellvitge — NA
Beckman Coulter, Inc.
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Creatine deficiency syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Creatine deficiency syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Creatine deficiency syndrome.
Community
No community posts yet. Be the first to share your experience with Creatine deficiency syndrome.
Start the conversation →Latest news about Creatine deficiency syndrome
Disease timeline:
New recruiting trial: International Registry Study of Neutral Lipid Storage Disease (NLSD) / Triglyceride Deposit Cardiomyovasculopathy (TGCV) and Related Diseases
A new clinical trial is recruiting patients for Creatine deficiency syndrome
New recruiting trial: CirrhosisRx CDS System
A new clinical trial is recruiting patients for Creatine deficiency syndrome
New recruiting trial: EUS-Gallbladder vs CDS as First Line in MBDO- Palliative (CARPEGIEM Trial)
A new clinical trial is recruiting patients for Creatine deficiency syndrome
New recruiting trial: Evaluation of the SCALED (SCaling AcceptabLE cDs)
A new clinical trial is recruiting patients for Creatine deficiency syndrome
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Questions for your doctor
Bring these to your next appointment
- Q1.Which specific type of creatine deficiency does my child have, and how does that affect treatment options?,How soon should we start creatine supplementation, and what dose is right?,Does my child need a special diet, and do we need to see a dietitian?,What developmental therapies do you recommend, and how often should we do them?,Should other family members be tested, including siblings or the mother if CTD is suspected?,Are there any clinical trials for creatine transporter deficiency that we should consider?,What signs should prompt us to call you or go to the emergency room?
Common questions about Creatine deficiency syndrome
What is Creatine deficiency syndrome?
Creatine deficiency syndrome (also called cerebral creatine deficiency syndrome) is a group of inherited metabolic disorders where the body cannot make or transport creatine properly. Creatine is a natural substance that helps supply energy to the brain and muscles. Without enough creatine reaching the brain, the nervous system cannot work as it should. There are three main types: guanidinoacetate methyltransferase (GAMT) deficiency, arginine:glycine amidinotransferase (AGAT) deficiency, and creatine transporter deficiency (CTD, also called SLC6A8 deficiency). All three types share many of th
At what age does Creatine deficiency syndrome typically begin?
Typical onset of Creatine deficiency syndrome is infantile. Age of onset can vary across affected individuals.
Which specialists treat Creatine deficiency syndrome?
9 specialists and care centers treating Creatine deficiency syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.